• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化相关糖尿病(CFRD):相关遗传因素概述

Cystic Fibrosis-Related Diabetes (CFRD): Overview of Associated Genetic Factors.

作者信息

Iafusco Fernanda, Maione Giovanna, Rosanio Francesco Maria, Mozzillo Enza, Franzese Adriana, Tinto Nadia

机构信息

Department of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II", 80131 Naples, Italy.

CEINGE Advanced Biotechnology, 80131 Naples, Italy.

出版信息

Diagnostics (Basel). 2021 Mar 22;11(3):572. doi: 10.3390/diagnostics11030572.

DOI:10.3390/diagnostics11030572
PMID:33810109
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8005125/
Abstract

Cystic fibrosis (CF) is the most common autosomal recessive disease in the Caucasian population and is caused by mutations in the CF transmembrane conductance regulator () gene that encodes for a chloride/bicarbonate channel expressed on the membrane of epithelial cells of the airways and of the intestine, as well as in cells with exocrine and endocrine functions. A common nonpulmonary complication of CF is cystic fibrosis-related diabetes (CFRD), a distinct form of diabetes due to insulin insufficiency or malfunction secondary to destruction/derangement of pancreatic betacells, as well as to other factors that affect their function. The prevalence of CFRD increases with age, and 40-50% of CF adults develop the disease. Several proposed hypotheses on how CFRD develops have emerged, including exocrine-driven fibrosis and destruction of the entire pancreas, as well as contrasting theories on the direct or indirect impact of mutation on islet function. Among contributors to the development of CFRD, in addition to genotype, there are other genetic factors related and not related to type 2 diabetes. This review presents an overview of the current understanding on genetic factors associated with glucose metabolism abnormalities in CF.

摘要

囊性纤维化(CF)是白种人群中最常见的常染色体隐性疾病,由囊性纤维化跨膜传导调节因子(CFTR)基因突变引起,该基因编码一种氯离子/碳酸氢根离子通道,表达于气道和肠道上皮细胞膜以及具有外分泌和内分泌功能的细胞上。CF常见的非肺部并发症是囊性纤维化相关糖尿病(CFRD),这是一种由于胰腺β细胞破坏/紊乱继发胰岛素不足或功能异常以及其他影响其功能的因素导致的独特糖尿病形式。CFRD的患病率随年龄增长而增加,40%至50%的成年CF患者会患上这种疾病。关于CFRD如何发展出现了几种假说,包括外分泌驱动的纤维化和整个胰腺的破坏,以及关于CFTR突变对胰岛功能直接或间接影响的不同理论。在CFRD的发病因素中,除了CFTR基因型外,还有其他与2型糖尿病相关和不相关的遗传因素。本综述概述了目前对与CF中葡萄糖代谢异常相关的遗传因素的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ef5/8005125/0b3b0b8e5614/diagnostics-11-00572-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ef5/8005125/0b3b0b8e5614/diagnostics-11-00572-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ef5/8005125/0b3b0b8e5614/diagnostics-11-00572-g001.jpg

相似文献

1
Cystic Fibrosis-Related Diabetes (CFRD): Overview of Associated Genetic Factors.囊性纤维化相关糖尿病(CFRD):相关遗传因素概述
Diagnostics (Basel). 2021 Mar 22;11(3):572. doi: 10.3390/diagnostics11030572.
2
Cystic Fibrosis-Related Diabetes: Pathophysiology and Therapeutic Challenges.囊性纤维化相关糖尿病:病理生理学与治疗挑战
Clin Med Insights Endocrinol Diabetes. 2019 May 28;12:1179551419851770. doi: 10.1177/1179551419851770. eCollection 2019.
3
Management of endocrine disease: Cystic fibrosis-related diabetes: novel pathogenic insights opening new therapeutic avenues.内分泌疾病的治疗:囊性纤维化相关性糖尿病:新的发病机制研究为治疗提供新途径。
Eur J Endocrinol. 2015 Apr;172(4):R131-41. doi: 10.1530/EJE-14-0644. Epub 2014 Oct 21.
4
The Potential Causes of Cystic Fibrosis-Related Diabetes.囊性纤维化相关性糖尿病的潜在病因。
Front Endocrinol (Lausanne). 2021 Jul 30;12:702823. doi: 10.3389/fendo.2021.702823. eCollection 2021.
5
Islet-intrinsic effects of CFTR mutation.囊性纤维化跨膜传导调节因子(CFTR)突变的胰岛内在效应。
Diabetologia. 2016 Jul;59(7):1350-1355. doi: 10.1007/s00125-016-3936-1. Epub 2016 Mar 31.
6
New Concepts in the Pathogenesis of Cystic Fibrosis-Related Diabetes.囊性纤维化相关性糖尿病发病机制的新概念。
J Clin Endocrinol Metab. 2022 May 17;107(6):1503-1509. doi: 10.1210/clinem/dgac020.
7
Pancreas and islet morphology in cystic fibrosis: clues to the etiology of cystic fibrosis-related diabetes.囊性纤维化中的胰腺和胰岛形态:囊性纤维化相关糖尿病病因的线索。
Front Endocrinol (Lausanne). 2023 Nov 23;14:1269139. doi: 10.3389/fendo.2023.1269139. eCollection 2023.
8
Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.囊性纤维化相关性糖尿病研讨会:涵盖疾病病理生理学、诊断和结局的研究重点。
Diabetes Care. 2023 Jun 1;46(6):1112-1123. doi: 10.2337/dc23-0380.
9
Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.囊性纤维化相关性糖尿病研讨会:涵盖疾病病理生理学、诊断和结局的研究重点。
Diabetes. 2023 Jun 1;72(6):677-689. doi: 10.2337/db22-0949.
10
Islet Function in the Pathogenesis of Cystic Fibrosis-Related Diabetes Mellitus.胰岛功能在囊性纤维化相关糖尿病发病机制中的作用
Clin Med Insights Endocrinol Diabetes. 2021 Jul 13;14:11795514211031204. doi: 10.1177/11795514211031204. eCollection 2021.

引用本文的文献

1
Evolution and Prognostic Variables of Cystic Fibrosis in Children and Young Adults: A Narrative Review.儿童和青年囊性纤维化的演变及预后变量:一项叙述性综述
Diagnostics (Basel). 2025 Aug 2;15(15):1940. doi: 10.3390/diagnostics15151940.
2
When Two Worlds Collide: Navigating Diabetes in Cystic Fibrosis.当两个世界碰撞:应对囊性纤维化合并糖尿病
Cureus. 2025 May 14;17(5):e84110. doi: 10.7759/cureus.84110. eCollection 2025 May.
3
Impact of Gene Modifiers on Cystic Fibrosis Phenotypic Profiles: A Systematic Review.基因修饰因子对囊性纤维化表型谱的影响:一项系统综述。

本文引用的文献

1
Hypoglycemia in cystic fibrosis during an extended oral glucose tolerance test.囊性纤维化患者在口服葡萄糖耐量试验中出现低血糖。
Pediatr Pulmonol. 2020 Dec;55(12):3391-3399. doi: 10.1002/ppul.25081. Epub 2020 Oct 16.
2
Fanconi-Bickel Syndrome: A Review of the Mechanisms That Lead to Dysglycaemia.范可尼-比克尔综合征:导致血糖异常的机制综述。
Int J Mol Sci. 2020 Aug 31;21(17):6286. doi: 10.3390/ijms21176286.
3
GCK-MODY in a child with cystic fibrosis: the doubt of the treatment plan.儿童囊性纤维化合并 GCK-MODY:治疗方案的疑问。
Hum Mutat. 2024 Oct 16;2024:6165547. doi: 10.1155/2024/6165547. eCollection 2024.
4
Association between cystic fibrosis transmembrane regulator genotype and clinical outcomes, glucose homeostasis indices and CF-related diabetes risk in adults with CF.囊性纤维化跨膜传导调节因子基因型与成年囊性纤维化患者临床结局、葡萄糖稳态指标及囊性纤维化相关糖尿病风险之间的关联
Genet Mol Biol. 2024 Mar 29;47(1):e20230021. doi: 10.1590/1678-4685-GMB-2023-0021. eCollection 2024.
5
An Update in Cystic Fibrosis-Related Diabetes in Children and Adolescents.儿童和青少年囊性纤维化相关糖尿病的最新进展
Children (Basel). 2023 Nov 30;10(12):1879. doi: 10.3390/children10121879.
6
Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis.囊性纤维化患者中非结核分枝杆菌肺病的临床管理中可治疗的特征和挑战。
Respir Res. 2023 Dec 16;24(1):316. doi: 10.1186/s12931-023-02612-1.
7
Oxidative Stress Biomarkers in Cystic Fibrosis and Cystic Fibrosis-Related Diabetes in Children: A Literature Review.儿童囊性纤维化及囊性纤维化相关糖尿病中的氧化应激生物标志物:文献综述
Biomedicines. 2023 Sep 29;11(10):2671. doi: 10.3390/biomedicines11102671.
8
Mathematical models of cystic fibrosis as a systemic disease.囊性纤维化作为一种系统性疾病的数学模型。
WIREs Mech Dis. 2023 Nov-Dec;15(6):e1625. doi: 10.1002/wsbm.1625. Epub 2023 Aug 6.
9
Exocrine-Endocrine Crosstalk: The Influence of Pancreatic Cellular Communications on Organ Growth, Function and Disease.外分泌-内分泌串扰:胰腺细胞通讯对器官生长、功能和疾病的影响。
Front Endocrinol (Lausanne). 2022 Jun 13;13:904004. doi: 10.3389/fendo.2022.904004. eCollection 2022.
10
Oral Glucose Tolerance Test in Patients with Cystic Fibrosis Compared to the Overweight and Obese: A Different Approach in Understanding the Results.囊性纤维化患者与超重及肥胖患者的口服葡萄糖耐量试验:理解结果的不同方法
Children (Basel). 2022 Apr 8;9(4):533. doi: 10.3390/children9040533.
J Pediatr Endocrinol Metab. 2020 Jul 13;33(10):1359-1362. doi: 10.1515/jpem-2020-0093.
4
Cystic fibrosis-related diabetes: an update on pathophysiology, diagnosis, and treatment.囊性纤维化相关性糖尿病:发病机制、诊断和治疗的最新进展。
J Pediatr Endocrinol Metab. 2020 Jul 28;33(7):835-843. doi: 10.1515/jpem-2019-0484.
5
Blood co-expression modules identify potential modifier genes of diabetes and lung function in cystic fibrosis.血液共表达模块鉴定囊性纤维化中糖尿病和肺功能的潜在修饰基因。
PLoS One. 2020 Apr 17;15(4):e0231285. doi: 10.1371/journal.pone.0231285. eCollection 2020.
6
TAS2R38 is a novel modifier gene in patients with cystic fibrosis.TAS2R38 是囊性纤维化患者的一个新型修饰基因。
Sci Rep. 2020 Apr 2;10(1):5806. doi: 10.1038/s41598-020-62747-9.
7
Maturity-onset diabetes of the young: Different diabetes in an infant with cystic fibrosis.青少年起病的成年型糖尿病:囊性纤维化患儿中的不同糖尿病。
Pediatr Pulmonol. 2020 May;55(5):E5-E7. doi: 10.1002/ppul.24746. Epub 2020 Mar 26.
8
Genetic Modifiers of Cystic Fibrosis-Related Diabetes Have Extensive Overlap With Type 2 Diabetes and Related Traits.囊性纤维化相关性糖尿病的遗传修饰因子与 2 型糖尿病和相关特征有广泛的重叠。
J Clin Endocrinol Metab. 2020 May 1;105(5):1401-15. doi: 10.1210/clinem/dgz102.
9
Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al.囊性纤维化相关性糖尿病在欧洲的流行情况、风险因素和结局;Olesen 等人。
J Cyst Fibros. 2020 Mar;19(2):321-327. doi: 10.1016/j.jcf.2019.10.009. Epub 2019 Oct 31.
10
Cystic fibrosis related diabetes: Pathophysiology, screening and diagnosis.囊性纤维化相关性糖尿病:病理生理学、筛查和诊断。
J Cyst Fibros. 2019 Oct;18 Suppl 2:S3-S9. doi: 10.1016/j.jcf.2019.08.016.